Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Mucosal Atomization Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The mucosal atomization devices market ...

The UK mucosal atomization device market is projected to grow at a 6.70% CAGR From 2024 to 2034, leading Western Europe. Non-invasive delivery systems are popular, driven by investment in healthcare ...

Nephron Pharmaceuticals announced a medical device recall due to a manufacturing defect found in the EZ Breathe Atomizer. The defect could result in the washer (Plate A) dislodging from the EZ Breathe ...

This report provides strategists, marketers and senior management with the critical information they need to assess the global mucosal atomization devices market. The global mucosal atomization ...

The mucosal atomization device market is expected to develop at a modest CAGR of 6.9% between 2024 and 2034, increasing from USD 570.52 million in 2024 to USD 1,110 million by 2034. The mucosal ...

Naloxone, the opioid overdose antidote, has become a vital tool in fighting the heroin and opioid epidemic. It can be administered with a syringe-like device that sprays the drug into the nose. But a ...

AVEO Vapor Devices, a pioneering manufacturer and supplier specializing in vape devices tailored for the cannabis industry, is pleased to announce the acquisition of licensing rights for two patents: ...

According to the latest report by Future Market Insights (FMI), the global mucosal atomization device market is on track to achieve a value of USD 570.52 million in 2024, with an anticipated expansion ...